Literature DB >> 27067662

A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese.

Teng Jiang1, Lan Tan2, Qi Chen3, Meng-Shan Tan4, Jun-Shan Zhou5, Xi-Chen Zhu6, Huan Lu6, Hui-Fu Wang6, Ying-Dong Zhang7, Jin-Tai Yu8.   

Abstract

Two recent studies have identified that a rare coding variant (p.R47H) in exon 2 of triggering receptor expressed on myeloid cells 2 (TREM2) gene is associated with Alzheimer's disease (AD) susceptibility in Caucasians. This association was not successfully replicated in Han Chinese, where this variant was rare or even absent. Previously, we resequenced TREM2 exon 2 to investigate whether additional rare variants conferred risk to AD in our cohort. Although several new variants had been identified, none of them was significantly associated with disease susceptibility. Here, to test whether TREM2 is truly a susceptibility gene of AD in Han Chinese, we extend our previous study by sequencing the other four exons of TREM2 in 988 AD patients and 1,354 healthy controls. We provided the first evidence that a rare coding variant (p.H157Y) in TREM2 exon 3 conferred a considerable risk of AD in our cohort (Pcorrected = 0.02, odds ratio = 11.01, 95% confidence interval: 1.38-88.05). This finding indicates that rare coding variants of TREM2 may play an important role in AD in Han Chinese.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Han Chinese; Rare coding variants; TREM2

Mesh:

Substances:

Year:  2016        PMID: 27067662     DOI: 10.1016/j.neurobiolaging.2016.02.023

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  29 in total

Review 1.  Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?

Authors:  Yuetiva Deming; Zeran Li; Bruno A Benitez; Carlos Cruchaga
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

2.  Identification of a rare coding variant in TREM2 in a Chinese individual with Alzheimer's disease.

Authors:  Luke W Bonham; Daniel W Sirkis; Jia Fan; Renan E Aparicio; Marian Tse; Eliana Marisa Ramos; Qing Wang; Giovanni Coppola; Howard J Rosen; Bruce L Miller; Jennifer S Yokoyama
Journal:  Neurocase       Date:  2017-02       Impact factor: 0.881

3.  Genetic Analysis of TREM2 Variants in Tunisian Patients with Alzheimer's Disease.

Authors:  Zied Landoulsi; Mouna Ben Djebara; Imen Kacem; Youssef Sidhom; Rym Kefi; Sonia Abdelhak; Amina Gargouri-Berrechid; Riadh Gouider
Journal:  Med Princ Pract       Date:  2018-05-03       Impact factor: 1.927

4.  TREM1: A Potential Therapeutic Target For Alzheimer's Disease.

Authors:  Khalil Saadipour
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

5.  Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.

Authors:  Claudia Olive; Laura Ibanez; Fabiana H Geraldo Farias; Fengxian Wang; John P Budde; Joanne B Norton; Jen Gentsch; John C Morris; Zeran Li; Umber Dube; Jorge Del-Aguila; Kristy Bergmann; Joseph Bradley; Bruno A Benitez; Oscar Harari; Anne Fagan; Beau Ances; Carlos Cruchaga; Maria Victoria Fernandez
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 6.  Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk.

Authors:  Anastasia G Efthymiou; Alison M Goate
Journal:  Mol Neurodegener       Date:  2017-05-26       Impact factor: 14.195

Review 7.  Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease.

Authors:  Sophia R L Vieira; Huw R Morris
Journal:  Front Neurol       Date:  2021-06-04       Impact factor: 4.003

8.  TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant.

Authors:  Peter Thornton; Jean Sevalle; Michael J Deery; Graham Fraser; Ye Zhou; Sara Ståhl; Elske H Franssen; Roger B Dodd; Seema Qamar; Beatriz Gomez Perez-Nievas; Louise Sc Nicol; Susanna Eketjäll; Jefferson Revell; Clare Jones; Andrew Billinton; Peter H St George-Hyslop; Iain Chessell; Damian C Crowther
Journal:  EMBO Mol Med       Date:  2017-10       Impact factor: 12.137

9.  An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.

Authors:  Kai Schlepckow; Gernot Kleinberger; Akio Fukumori; Regina Feederle; Stefan F Lichtenthaler; Harald Steiner; Christian Haass
Journal:  EMBO Mol Med       Date:  2017-10       Impact factor: 12.137

Review 10.  TREM2 in Neurodegenerative Diseases.

Authors:  Taylor R Jay; Victoria E von Saucken; Gary E Landreth
Journal:  Mol Neurodegener       Date:  2017-08-02       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.